Aurinia Pharmaceuticals Inc. (AUPH) intrinsic value & 10-year financials
Aurinia Pharmaceuticals Inc. (AUPH) has a Graham intrinsic value of $68.76 per share. At $16.51 on Oct 17, 2026, the stock trades 76% below that value. Over the last 9 fiscal years revenue grew 150.1% a year to $283.1M, with an average return on invested capital of 113.0%.
- Graham intrinsic value
- $68.76
- Share price (Oct 17, 2026)
- $16.51
- Price vs Graham value
- 76% below
- Market cap
- $2.3B
- Revenue (FY2025)
- $283.1M
- Revenue growth (9-yr CAGR)
- 150.1%
- ROIC (10-yr avg)
- 113.0%
- Free cash flow (FY2025)
- $135.4M
AUPH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $283.1M | $287.2M | $2.07 | $135.4M | 37.1% | 22.9% |
| FY2024 | $235.1M | $5.8M | $0.04 | $44.1M | -2.0% | -0.9% |
| FY2023 | $175.5M | -$78.0M | -$0.54 | -$34.2M | -52.2% | -25.1% |
| FY2022 | $134.0M | -$108.2M | -$0.76 | -$79.8M | -83.2% | -38.9% |
| FY2021 | $45.6M | -$181.0M | -$1.40 | -$158.0M | -396.3% | -90.8% |
| FY2020 | $50.1M | -$102.7M | -$0.87 | -$75.4M | -208.1% | -153.7% |
| FY2019 | $318.0K | -$88.4M | -$0.95 | -$63.7M | -28598.4% | 1225.8% |
| FY2018 | $463.0K | -$53.1M | — | -$51.7M | -11930.9% | -35.2% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Aurinia Pharmaceuticals Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Aurinia Pharmaceuticals Inc. has historically struggled to out-earn its cost of capital, averaging just -17.4% ROIC.
Aurinia Pharmaceuticals Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Aurinia Pharmaceuticals Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $68.76 per share.